Lakefront Biotherapeutics · EURONEXT:LKFT
EcoR1 Capital, LLC reported a 13.22% stake in Lakefront Biotherapeutics (Schedule 13D/A)
Event Jul 24, 2025 · Filed Jul 28, 2025
EcoR1 Capital, LLC reported a 13.22% stake in Lakefront Biotherapeutics, 8,714,522 shares, with active intent on Jul 24, 2025. Filed Jul 28, 2025 (Schedule 13D/A).
- Stake
- 13.22%
- Shares
- 8,714,522
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 13.22% | 8,714,522 |
| Oleg Nodelman | 13.22% | 8,714,522 |
| EcoR1 Capital Fund Qualified, L.P. | 12.43% | 8,192,077 |
| EcoR1 Capital Fund, L.P. | 0.79% | 522,445 |
Source
Related
- Lakefront Biotherapeutics
- EcoR1 Capital, LLC
- Lakefront Biotherapeutics shareholders
- Schedule 13D/A · EcoR1 Capital, LLC · May 19, 2025
- Schedule 13G · Madison Avenue Partners, LP · Jun 23, 2026
- Schedule 13G · Tang Capital Management LLC · Oct 29, 2025
- Schedule 13D · Tang Capital Management LLC · Feb 14, 2025
- Schedule 13D/A · Gilead Sciences, Inc. · Jan 10, 2025